Morton County Hospital

CLIA Laboratory Citation Details

2
Total Citations
15
Total Deficiencyies
14
Unique D-Tags
CMS Certification Number 17D0047368
Address 445 Hilltop, Elkhart, KS, 67950
City Elkhart
State KS
Zip Code67950
Phone(620) 697-2141

Citation History (2 surveys)

Survey - February 8, 2023

Survey Type: Standard

Survey Event ID: 43N211

Deficiency Tags: D5471 D5807

Summary:

Summary Statement of Deficiencies D5471 CONTROL PROCEDURES CFR(s): 493.1256(e)(1)(g) (e) For reagent, media, and supply checks, the laboratory must do the following: (e)(i) Check each batch (prepared in-house), lot number (commercially prepared) and shipment of reagents, disks, stains, antisera, (except those specifically referenced in 493.1261 (a)(3)) and identification systems (systems using two or more substrates or two or more reagents, or a combination) when prepared or opened for positive and negative reactivity, as well as graded reactivity, if applicable. (g) The laboratory must document all control procedures performed. This STANDARD is not met as evidenced by: Based on the review of quality control (QC) records, lack of documentation and interview with the technical consultant #1 (TC#1), the laboratory failed to document QC for Gram Stains for positive and negative reactivity prior to use for patient testing. Findings: 1. Review of the QC records for Gram Stain revealed no QC testing had been performed since 5/20/21. Exact date not available. 2. The current documentation for the Gram Stain QC was not made available at the time of survey. 3. Interview with TC#1 on 2/8/23 at 10:45 a.m. confirmed, the laboratory failed to document QC for Gram Stains for positive and negative reactivity prior to use for patient testing. D5807 TEST REPORT CFR(s): 493.1291(d) Pertinent "reference intervals" or "normal" values, as determined by the laboratory performing the tests, must be available to the authorized person who ordered the tests and, if applicable, the individual responsible for using the test results. This STANDARD is not met as evidenced by: Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- Based on review of approved reference ranges in the laboratory "Hematology Reference Range" procedure manual and interview with the technical consultant #1 (TC#1), the laboratory failed to ensure the test report included correct normal ranges and unit of reports as determined by the laboratory "Reference Range" policy at time of survey. Findings: 1. Review of the patient reports from the Laboratory Information System (LIS) revealed 18 out of 18 parameters for normal ranges and unit of reports did not correctly match those reference ranges for the complete blood count (CBC) test in the laboratory "Reference Range" procedure manual. LIS patient report (Unisex): WBC 3.6 - 10.7 10*3/uL RBC 4.4 - 5.9 10*6/ul HGB 13.0 - 18.0 g/dL HCT 40 - 52 % MCV 80.0 - 98.0 fL MCH 26.0 - 34.0 pg MCHC 31 - 37 g/dL PLATELETS 140 - 440 10^3/uL NEUT % None % LYMPH % None % MONO % None % EOS % None % BASO% None % NEUT # None, No Unit of Report LYMPH # None 10^9/L MONO # None 10^9/L EOS # None, No Unit of Report BASO # None, No Unit of Report Procedure Manual Parameters (Unisex): WBC 2.5 - 20,000/cumm RBC 3.0 - 6.0 mil/cumm HGB 8.0 - 18.0 gm/dL HCT 24.0 - 54.0 % MCV 72.0 - 105.0 cumm MCH 30.0 - 36.0 pg MCHC 30.0 - 36.0 gm/dL PLT 75 - 500,000/mm3 Neut 30.0 - 90.0 % Lymph 10.0 - 45.0 % Mono 1.0 - 10.0 % Eos 0.5 - 10.0 % Baso 0.1 - 3.0 % LUC 0.0 - 3.5 % Neut# None Listed Lymph# None Listed Mono# None Listed Eos# None Listed Baso# None Listed 2. Interview with TC#1 on 2/8/2023 at 11:20 a.m. confirmed, the laboratory failed to ensure the correct reference ranges and unit of reports approved in the "Reference Range" procedure manual were in correlation with the LIS patient report. -- 2 of 2 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - May 20, 2021

Survey Type: Standard

Survey Event ID: U0PY11

Deficiency Tags: D5291 D5403 D5805 D5807 D6007 D6031 D6032 D6045 D6108 D6117 D6118 D6119 D6123

Summary:

Summary Statement of Deficiencies D5291 GENERAL LABORATORY SYSTEMS QUALITY ASSESSMENT CFR(s): 493.1239(a) The laboratory must establish and follow written policies and procedures for an ongoing mechanism to monitor, assess, and, when indicated, correct problems identified in the general laboratory systems requirements specified at 493.1231 through 493.1236. This STANDARD is not met as evidenced by: Based on lack of documents and interview, the laboratory failed to have and follow policies and procedures to monitor, assess, and when indicated correct problems identified in general laboratory system. Findings: 1. No Quality Assurance (QA) plan or procedure was made available at the time of survey. 2. Interview with the general supervisor (GS) 5/20/21 at 10:15 a.m. confirmed, the laboratory failed to have and follow policies and procedures to monitor, assess, and when indicated correct problems identified in general laboratory system. D5403 PROCEDURE MANUAL CFR(s): 493.1251(b) The procedure manual must include the following when applicable to the test procedure: (1) Requirements for patient preparation; specimen collection, labeling, storage, preservation, transportation, processing, and referral; and criteria for specimen acceptability and rejection as described in 493.1242. (2) Microscopic examination, including the detection of inadequately prepared slides. (3) Step-by-step performance of the procedure, including test calculations and interpretation of results. (4) Preparation of slides, solutions, calibrators, controls, reagents, stains, and other materials used in testing. (5) Calibration and calibration verification procedures. (6) The reportable range for test results for the test system as established or verified in 493.1253. (7) Control procedures. (8)

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access